| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 15 |
| 1 | DEXAMETHASONE 1.5 MG | 15 |
| 2 | BORTEZOMIB | 14 |
| 3 | DARATUMUMAB | 12 |
| 4 | CYCLOPHOSPHAMIDE | 9 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 9 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 9 |
| 7 | LENALIDOMIDE | 9 |
| 8 | THALIDOMIDE | 9 |
| 9 | PREDNISONE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 1 | 0.0102 |
| 1 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| 2 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| 3 | CARMUSTINE | 3 | 0.0006 |
| 4 | VINBLASTINE SULFATE | 1 | 0.0005 |
| 5 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 6 | CALCITONIN SALMON | 1 | 0.0003 |
| 7 | CHLORPROMAZINE | 2 | 0.0003 |
| 8 | MITOXANTRONE HYDROCHLORIDE | 2 | 0.0003 |
| 9 | DIPHENHYDRAMINE HCL | 3 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 22 |
| 1 | Proteasome Inhibitor [EPC] | 15 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 13 |
| 3 | Alkylating Drug [EPC] | 12 |
| 4 | Thalidomide Analog [EPC] | 10 |
| 5 | Topoisomerase Inhibitor [EPC] | 6 |
| 6 | Benzodiazepine [EPC] | 5 |
| 7 | Opioid Agonist [EPC] | 5 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 4 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 13 | 0.0022 |
| 1 | Calcitonin [EPC] | 1 | 0.0003 |
| 2 | Proteasome Inhibitor [EPC] | 15 | 0.0001 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Topoisomerase Inhibitor [EPC] | 6 | 0.0001 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 12 | 0.0000 |
| 7 | Histamine-1 Receptor Antagonist [EPC] | 3 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |